Recent investigations into this medication are uncovering exciting potential beyond its initial indication for type 2 diabetes mellitus. Experts are closely analyzing how this GLP-1 receptor agonist affects weight management, the heart, and potentially cognitive function. These findings suggest a extensive spectrum of future treatments, fueling add